Further evidence on gabapentinoid efficacy is required but work in this field will be challenging

Sara Muller; James Bailey; Ram Bajpai; Toby Helliwell; Sarah A. Harrisson; Rebecca Whittle; Christian D. Mallen; Julie Ashworth

doi:10.1097/j.pain.0000000000003454

Further evidence on gabapentinoid efficacy is required but work in this field will be challenging

Sara Muller^*, James Bailey, Ram Bajpai, Toby Helliwell, Sarah A. Harrisson, Rebecca Whittle, Christian D. Mallen, Julie Ashworth

^*Corresponding author for this work

Applied Health Sciences

Research output: Contribution to journal › Comment/debate › peer-review

Original language	English
Pages (from-to)	464-465
Number of pages	2
Journal	Pain
Volume	166
Issue number	2
DOIs	https://doi.org/10.1097/j.pain.0000000000003454
Publication status	Published - 1 Feb 2025

ASJC Scopus subject areas

Neurology
Clinical Neurology
Anesthesiology and Pain Medicine

Access to Document

10.1097/j.pain.0000000000003454Licence: None: All rights reserved

1 Article

Risk of adverse outcomes during gabapentinoid therapy and factors associated with increased risk in UK primary care using the clinical practice research datalink: a cohort study
Muller, S., Bailey, J., Bajpai, R., Helliwell, T., Harrisson, S. A., Whittle, R., Mallen, C. D. & Ashworth, J., Oct 2024, In: Pain. 165, 10, p. 2282-2290 9 p.
Research output: Contribution to journal › Article › peer-review

Open Access
File
3 Downloads (Pure)

Cite this

@article{49f247d7919846be929f1cd765b29a06,

title = "Further evidence on gabapentinoid efficacy is required but work in this field will be challenging",

author = "Sara Muller and James Bailey and Ram Bajpai and Toby Helliwell and Harrisson, {Sarah A.} and Rebecca Whittle and Mallen, {Christian D.} and Julie Ashworth",

year = "2025",

month = feb,

day = "1",

doi = "10.1097/j.pain.0000000000003454",

language = "English",

volume = "166",

pages = "464--465",

journal = "Pain",

issn = "0304-3959",

publisher = "Lippincott Williams and Wilkins",

number = "2",

}

TY - JOUR

T1 - Further evidence on gabapentinoid efficacy is required but work in this field will be challenging

AU - Muller, Sara

AU - Bailey, James

AU - Bajpai, Ram

AU - Helliwell, Toby

AU - Harrisson, Sarah A.

AU - Whittle, Rebecca

AU - Mallen, Christian D.

AU - Ashworth, Julie

PY - 2025/2/1

Y1 - 2025/2/1

UR - http://www.scopus.com/inward/record.url?scp=85215255872&partnerID=8YFLogxK

U2 - 10.1097/j.pain.0000000000003454

DO - 10.1097/j.pain.0000000000003454

M3 - Comment/debate

C2 - 39792944

AN - SCOPUS:85215255872

SN - 0304-3959

VL - 166

SP - 464

EP - 465

JO - Pain

JF - Pain

IS - 2

ER -

Further evidence on gabapentinoid efficacy is required but work in this field will be challenging

ASJC Scopus subject areas

Access to Document

Research output

Risk of adverse outcomes during gabapentinoid therapy and factors associated with increased risk in UK primary care using the clinical practice research datalink: a cohort study

Cite this